Dabigatran: New Doubts About Novel Anticoagulant

Dabigatran, the first alternative to the age-old anticoagulant warfarin, is coming under increased scrutiny due to reports of increased risk of cardiac events according to The Lancet. A few months ago, trauma surgeons wrote in The New England Journal of Medicine about patients on dabigatran dying needlessly from internal bleeding after trauma, such as car accidents, because the only way to reverse its effect is by hemodialysis, which is not usually available on an emergency basis in community hospitals.

Anticoagulant loses its lustre : The Lancet.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s